BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:The Swedish model for CVD prevention:  Public Health cultivation c
 ombined with individual health dialogues in Primary Care - Professor Lars 
 Weinehall\, Department of Public Health and Clinical Medicine\, Umeå Univ
 ersity\, Sweden
DTSTART:20170407T120000Z
DTEND:20170407T130000Z
UID:TALK71761@talks.cam.ac.uk
CONTACT:Lucy Lloyd
DESCRIPTION:In Sweden\, mortality from cardiovascular diseases (CVD) incre
 ased steadily during the 20th century and in the mid-1980s. The county of 
 Västerbotten had the highest mortality. Therefore\, a community intervent
 ion programme was launched - the Västerbotten Intervention Programme (VIP
 ). The programme combines a population-based strategy directed towards the
  public and an invitation to all middle-aged persons at ages 40\, 50 and 6
 0 years for a systematic risk factor screening and a individual health dia
 logue about lifestyle habits. VIP is one of very few ongoing sustainable C
 VD prevention programs globally\, that are integrated into primary care ro
 utines\, that target selected age-groups in middle-age\, and that combine 
 low-risk population and high-risk individual level strategies for preventi
 on\n\nTo evaluate the impact of VIP during the first 17 years of the progr
 amme\, (a) all eligible individuals (target group impact)\, and (b) VIP pa
 rticipants were compared with the general Swedish population in a dynamic 
 cohort study. All individuals aged 40\, 50 or 60\, residing in Västerbott
 en County\, Sweden\, between 1990 and 2006 (N=101 918) were followed from 
 their first opportunity to participate in VIP until age 75\, study end-poi
 nt or prior death. Primary outcomes were all-cause and CVD mortality. \n\n
 There is strong evidence that the VIP has brought about a substantial redu
 ction on premature mortality. We conclude that the VIP model of CVD preven
 tion is able to impact on all-cause and cardiovascular mortality when eval
 uated according to the intention-to-treat principle.\n
LOCATION:Large Seminar Room\, Institute of Public Health\, Forvie Site\, R
 obinson Way\, Cambridge CB2 0SR
END:VEVENT
END:VCALENDAR
